Education
About Us
Working with TipRanks
Follow Us
Golden Throat Holdings Group Co Ltd (HK:6896)
:6896
RESEARCH TOOLSreports
6896 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$2.90 - HK$5.65
Previous CloseN/A
Volume368.50K
Average Volume (3M)1.03M
Market Cap
HK$3.41B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)9.9
Beta0.21
Next Earnings
Aug 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 16, 2025Dividend Yield10.62%
Share Statistics
EPS (TTM)0.27
Shares Outstanding739,302,000
10 Day Avg. Volume1,150,950
30 Day Avg. Volume1,026,677
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Golden Throat Holdings Group Co Ltd News
6896 FAQ
What was Golden Throat Holdings Group Co Ltd’s price range in the past 12 months?
Golden Throat Holdings Group Co Ltd lowest stock price was HK$2.90 and its highest was HK$5.65 in the past 12 months.
What is Golden Throat Holdings Group Co Ltd’s market cap?
Golden Throat Holdings Group Co Ltd’s market cap is HK$3.41B.
When is Golden Throat Holdings Group Co Ltd’s upcoming earnings report date?
Golden Throat Holdings Group Co Ltd’s upcoming earnings report date is Aug 27, 2025 which is in 24 days.
How were Golden Throat Holdings Group Co Ltd’s earnings last quarter?
Golden Throat Holdings Group Co Ltd released its earnings results on Mar 28, 2025. The company reported HK$0.271 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.271.
Is Golden Throat Holdings Group Co Ltd overvalued?
According to Wall Street analysts Golden Throat Holdings Group Co Ltd’s price is currently Overvalued.
Does Golden Throat Holdings Group Co Ltd pay dividends?
Golden Throat Holdings Group Co Ltd pays a Annually dividend of HK$0.5 which represents an annual dividend yield of 10.62%. See more information on Golden Throat Holdings Group Co Ltd dividends here
What is Golden Throat Holdings Group Co Ltd’s EPS estimate?
Golden Throat Holdings Group Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Golden Throat Holdings Group Co Ltd have?
Golden Throat Holdings Group Co Ltd has 739,302,000 shares outstanding.
What happened to Golden Throat Holdings Group Co Ltd’s price movement after its last earnings report?
Golden Throat Holdings Group Co Ltd reported an EPS of HK$0.271 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Golden Throat Holdings Group Co Ltd?
Currently, no hedge funds are holding shares in HK:6896
Golden Throat Holdings Group Co Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
63.24%
12-Months-Change
Fundamentals
Return on Equity
21.15%
Trailing 12-Months
Asset Growth
-5.35%
Trailing 12-Months
Company Description
Golden Throat Holdings Group Co Ltd
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
Technical Analysis
PuraPharm Corp. Ltd.
―
JBM (Healthcare) Ltd.
―
Dawnrays Pharmaceutical Holdings Ltd.
―
China Shineway Pharmaceutical Group Limited
―
Zhongzhi Pharmaceutical Holdings Limited
―
Ownership Overview
―
Insiders
0.29%
Mutual Funds
― Other Institutional Investors
99.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---